PIK3CA and diffuse intrinsic pontine glioma: However, analysis of diffuse gliomas included in this database showed no difference in paxalisib sensitivity between cell lines harboring mutant- and WT-PIK3CA, adding further relevance of targeting this pathway across patients with DIPG.